BLCM is requesting that the SEC allow these documents to remain redacted until Oct-Nov 2017, which is an unusually short extension for such a request.
Do they expect FDA approval before this date? I can't figure out where BLCM stands right now.They sure do have a lot going on in the pipelines with others, thats for sure.